Stanford V

WikiDoc Resources for Stanford V
Articles
Most recent articles on Stanford V Most cited articles on Stanford V Review articles on Stanford V Articles on Stanford V in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Stanford V Images of Stanford V Photos of Stanford V Podcasts & MP3s on Stanford V Videos on Stanford V
Evidence Based Medicine
Cochrane Collaboration on Stanford V Bandolier on Stanford V TRIP on Stanford V
Clinical Trials
Ongoing Trials on Stanford V at Clinical Trials.gov Trial results on Stanford V Clinical Trials on Stanford V at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Stanford V NICE Guidance on Stanford V NHS PRODIGY Guidance FDA on Stanford V CDC on Stanford V
Books
Books on Stanford V
News
Stanford V in the news Be alerted to news on Stanford V News trends on Stanford V
Commentary
Blogs on Stanford V
Definitions
Definitions of Stanford V
Patient Resources / Community
Patient resources on Stanford V Discussion groups on Stanford V Patient Handouts on Stanford V Directions to Hospitals Treating Stanford V Risk calculators and risk factors for Stanford V
Healthcare Provider Resources
Symptoms of Stanford V Causes & Risk Factors for Stanford V Diagnostic studies for Stanford V Treatment of Stanford V
Continuing Medical Education (CME)
CME Programs on Stanford V
International
Stanford V en Espanol Stanford V en Francais
Business
Stanford V in the Marketplace Patents on Stanford V
Experimental / Informatics
List of terms related to Stanford V

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Stanford V is a chemotherapy regimen designed for Hodgkin's lymphoma that consists of the following:

• Mechlorethamine
• Doxorubicin
• Vinblastine
• Vincristine
• Bleomycin
• Etoposide
• Prednisone

It is a newer method than MOPP or ABVD, the two previous most common treatments for Hodgkin's lymphoma.

The chemotherapy part of Stanford V treatment can last anywhere from 8 to 12 weeks, depending on the staging of the disease. In many cases, this is followed by radiation therapy for anywhere from 2 to 6 weeks to the affected areas of the body.

It is believed that Stanford V is at least as effective as other methods of treatment. Stanford V is a more rigorously administered form of chemotherapy, with treatments roughly twice as fast as those of other Hodgkin's lymphoma treatments; however, this is tempered by the need for radiation therapy in most cases which is not typically required under ABVD.

External links

• Lymphoma Information Network
• PMID 11821442
• Includes table for schedule

Template:Chemotherapeutic Agents Template:SIB Template:WH Template:WS